Key facts
- Curvafix’s last known valuation is $20.8M (Dec 2022).
- It has raised $34.8M across 3 recorded rounds; the latest was Early Stage VC ($45.1M) in Jun 2023.
- Notable investors include Keiretsu Forum, Rockies Venture Club, Denniston Family Office, Alliance of Angels, Ariel Savannah Angel Partners — 18 tracked in total.
- Curvafix has filed 5 Form Ds with the SEC since 2018, most recently Mar 2025 ($45.1M sold to 46 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for Curvafix
Funding rounds
3 roundsAbout Curvafix
Developer of implantable medical devices designed to fulfill unmet needs in pelvic trauma. The company's devices are capable of following the natural bone shape and filling space within curved bones such as the pelvis, enabling doctors to perform simple and short surgeries and help patients get a speedy recovery.
- Sector
- Healthcare
- HQ
- Bellevue, WA, United States
- Founded
- 2013
- Employees
- 36
- Website
- curvafix.com/
- Ownership
- Privately Held (backing)
Curvafix doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Curvafix shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Curvafix in its N-PORT filings yet. We sweep new filings monthly.